October 27, 2016
BENEFITING: Alliance for Cancer Gene Therapy, Inc.
Thank you for selecting the Alliance for Cancer Gene Therapy (ACGT) for the Revlon LOVE IS ON Million Dollar Challenge.
Since 2001, ACGT is the nation’s only non-profit dedicated exclusively to cell and gene therapy treatments for all types of cancer. One hundred percent of contributions go directly to research. ACGT has funded 50 grants in the U.S. and Canada since its founding that accelerates critically needed innovative research. Since its inception, ACGT has awarded 34 grants to Young Investigators and 16 grants to Clinical Investigators, totaling more than $26 million in funding. ACGT has been the funding arm for breakthroughs in cancer treatments such as the work by ACGT grantees like Dr. Carl June at the University of Pennsylvania and his work successfully treating leukemia through cancer gene therapy, which has been touted in recent national documentaries aired on PBS and HBO and are showing a 90 percent remission rate of children and adults with acute lymphoblastic leukemia that have gone into remission after participating in a personalized cellular therapy trial. ACGT-funded work is also attracting increasing attention from the pharmaceutical industry, which is swiftly discovering the potential of cell and gene therapies.
Choose Love. Choose Progress. Choose Survival. Choose ACGT.